(SY1) Symrise - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000SYM9999
SY1: Fragrances, Flavorings, Cosmetics, Ingredients, Flavors, Scents
Symrise AG is a global leader in the creation of fragrances, flavors, and functional ingredients, operating across Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. The company is structured into two core segments: Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health division specializes in functional ingredients and solutions for food and beverages, including savory flavors, sustainable and natural ingredients for food and beverage manufacturers, baby food, and dietary supplements. It also offers tailored solutions for pet food and fish feed manufacturers, along with probiotics for functional foods and supplements. The Scent & Care division focuses on fragrance ingredients, aroma molecules, cosmetic ingredients, and mint flavors, providing these to manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. Established in 1874 and headquartered in Holzminden, Germany, Symrise AG has a rich history of innovation in the specialty chemicals sector.
From an investment perspective, Symrise AG presents a compelling profile. With a market capitalization of 14,913.67 million EUR, the company is well-established in its industry. Its current P/E ratio stands at 37.97, with a forward P/E of 27.62, indicating expectations of future growth. The P/B ratio of 4.09 reflects the markets valuation of its assets, while the P/S ratio of 3.14 provides insight into its revenue generation efficiency. These metrics highlight Symrises position as a mature player with significant market presence and growth potential. The companys focus on sustainability, natural ingredients, and innovation aligns with global consumer trends, making it an attractive option for investors seeking exposure to the specialty chemicals and consumer goods sectors.
Exchange: XETRA
Type: Common Stock
Country Origin: Germany
GICS Sub Industry: Specialty Chemicals
Web URL: https://www.symrise.com
Market Cap or AUM: 14,913.67M EUR
P/E: 37.97
P/E Forward: 27.62
P/B: 4.09
P/S: 3.14
Additional Sources for SY1 Stock
SY1 Stock Overview
| Market Cap in USD | 14,209m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception |
SY1 Stock Ratings
| Growth 5y | -11.5% |
| Fundamental | 1.66% |
| Dividend | 36.6% |
| Rel. Strength | 6.19 |
| Analysts | - |
| Fair Price Momentum | 84.31 EUR |
| Fair Price DCF | 39.36 EUR |
SY1 Dividends
| Dividend Yield 12m | 2.24% |
| Yield on Cost 5y | 2.54% |
| Annual Growth 5y | -10.35% |
| Payout Consistency | 96.7% |
SY1 Growth Ratios
| Growth Correlation 3m | -78.3% |
| Growth Correlation 12m | -54% |
| Growth Correlation 5y | -9% |
| CAGR 5y | 1.14% |
| CAGR/Max DD 5y | 0.04 |
| Sharpe Ratio 12m | -0.09 |
| Alpha | -11.41 |
| Beta | 0.501 |
| Volatility | 21.49% |
| Current Volume | 557.2k |
| Average Volume 20d | 507.1k |
As of April 09, 2025, the stock is trading at EUR 91.66 with a total of 557,224 shares traded.
Over the past week, the price has changed by -5.04%, over one month by -6.07%, over three months by -7.17% and over the past year by -13.40%.
Neither. Based on ValueRay Fundamental Analyses, Symrise is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SY1 as of April 2025 is 84.31. This means that SY1 is currently overvalued and has a potential downside of -8.02%.
Symrise has no consensus analysts rating.
According to ValueRays Forecast Model, SY1 Symrise will be worth about 92.2 in April 2026. The stock is currently trading at 91.66. This means that the stock has a potential upside of +0.53%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 117.9 | 28.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 92.2 | 0.5% |